levodopa has been researched along with Neuroleptic Malignant Syndrome in 70 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (17.14) | 18.7374 |
1990's | 23 (32.86) | 18.2507 |
2000's | 21 (30.00) | 29.6817 |
2010's | 11 (15.71) | 24.3611 |
2020's | 3 (4.29) | 2.80 |
Authors | Studies |
---|---|
Jiang, W; Li, R; Lin, Y; Ma, L; Zhang, N | 1 |
Bin, Q; Hantao, S; JiYi, X; Lijiao, Z | 1 |
Doherty, AM; Flood, J; O'Keeffe, S; Talty, M; Waqas, S | 1 |
Manjunath, MB; Ray, A; Sahu, H; Vikram, NK | 1 |
Casier, I; Hantson, P; Jeanjean, A | 1 |
Ando, Y; Sakamoto, M; Shindo, Y; Shinoda, M; Tateda, T | 1 |
Anticoli, S; De Pandis, MF; Fiore, S; Persichino, L | 1 |
Fukuda, K | 1 |
Madigan, EJ | 1 |
Bonanni, L; Cossu, G; Manca, D; Onofrj, M; Stocchi, F; Thomas, A | 1 |
McKeith, I | 1 |
Heinz, A; Majic, T; Mell, T; Rapp, MA | 1 |
Moreno-Salcedo, JM; Ramírez-Relinque, L; Romero, FJ; Santisteban-López, Y | 1 |
Bonnici, A; Hornstein, D; Ruiner, CE; St-Laurent, L | 1 |
Man, SP | 1 |
Birthi, P; McDowell, S; Perry, D; Salles, S | 1 |
Ichinose, H; Ihara, M; Ikeda, A; Kawamoto, Y; Kohara, N; Nishida, T; Saiki, H; Shibasaki, H; Takagi, S; Takao, S; Urano, F | 1 |
Reingardiene, D | 1 |
Agid, Y; Bejjani, BP; Houeto, JL; Mallet, L; Mesnage, V; Welter, ML | 1 |
Serrano-Dueñas, M | 1 |
Hillis, RE; Lee, DA | 1 |
Kuno, S; Mizuno, Y; Mizuta, E; Takubo, H | 1 |
Hanyu, N; Hashimoto, T; Tabata, K; Tokuda, T; Yanagisawa, N | 1 |
Mizuno, Y; Shimoda-Matsubayashi, S; Takubo, H | 1 |
Kaji, M; Metoki, N; Sato, Y; Satoh, K; Yoshida, H | 1 |
Adarraga Cansino, MD; Rosa Jiménez, F; Velasco Malagón, MJ; Zambrana García, JL | 1 |
Ladha, SS; Shill, HA; Walker, R | 1 |
Onofrj, M; Thomas, A | 1 |
Aydemir, T; Aydin, B; Hanoglu, L; Meral, H; Oral, T; Ozer, F | 1 |
Ward, C | 1 |
Herkes, GK; McKay, D; Meagher, LJ; Needham, M | 1 |
Tarsy, D | 1 |
Kuno, S; Mizuta, E; Nakatake, M; Yamasaki, S | 1 |
Abraham, OC; Archana, S; Cherian, AM; Kurien, T; Rajeev, KK | 1 |
Cape, G | 1 |
Hirai, S; Kondo, T; Mizuno, Y; Mori, H; Suda, K; Tanabe, K; Yokochi, F | 1 |
Kornhuber, J; Weller, M | 1 |
Kaufman, BS; Young, CC | 1 |
del Toro Cervera, J; García Castaño, J; Muiño Miguez, A; Segado Soriano, A | 1 |
Cernek, PK; Shoop, SA | 1 |
Ishiguro, T; Nisijima, K; Noguti, M | 1 |
Kobayashi, T; Muneta, S; Saeki, H | 1 |
Egi, N; Harada, T; Kumagai, R; Kurokawa, K; Nakamura, S; Okazaki, M; Shimote, K | 1 |
Sunohara, N | 1 |
Bonoma, RA; Iwuagwu, CU; Riley, D | 1 |
Chew, EL; Ong, KC; Ong, YY | 1 |
Susman, VL | 1 |
Frucht, SJ; Gordon, PH | 1 |
Ogawa, N; Yamawaki, Y | 2 |
Akai, M; Idemura, Y; Ishizaki, T; Matsubara, R; Miyaho, S; Nakaguki, K; Nakai, T; Sasaki, F; Uchiki, H | 1 |
Bonuccelli, U; Corsini, GU; Muratorio, A; Piccini, P | 1 |
Lefeber, EJ; Rainer, C; Scheinost, NA | 1 |
Altus, P; Hencey, MA; Weissman, MS | 1 |
Ito, H; Kikuchi, H; Noda, S; Yamamoto, A; Yamamoto, H | 1 |
Goldswain, PR; Harrison, WB; Reutens, DC | 1 |
Montastruc, JL; Rascol, O; Salachas, F | 1 |
Meltzer, HY; Parsa, MA; Ramirez, LF; Rohr, T | 1 |
Clarke, CE; Green, MH; Shand, D; Yuill, GM | 1 |
Gibb, WR | 1 |
Greenberg, HS; Hirschorn, KA | 1 |
Harris, M; Nora, L; Tanner, CM | 1 |
Lambrecht, ER; Meems, BJ | 1 |
Lazarus, A | 1 |
Iacono, RP; Sandyk, R | 1 |
Gibb, WR; Griffith, DN | 1 |
Di Battista, G; Di Meo, L; Figà-Talamanca, L; Gualandi, C; Lo Russo, F; Neri, G | 1 |
Feinberg, SS; Feldman, RG; Friedman, JH | 1 |
Genís, D | 1 |
Ezrielev, GZ | 1 |
10 review(s) available for levodopa and Neuroleptic Malignant Syndrome
Article | Year |
---|---|
Emergencies in parkinsonism: akinetic crisis, life-threatening dyskinesias, and polyneuropathy during L-Dopa gel treatment.
Topics: Antiparkinson Agents; Dyskinesia, Drug-Induced; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinsonian Disorders; Polyneuropathies | 2009 |
[Neuroleptic malignant syndrome].
Topics: Acute Kidney Injury; Adult; Amantadine; Bromocriptine; Carbidopa; Contraindications; Dantrolene; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Female; Humans; Intensive Care Units; Levodopa; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Prognosis; Rhabdomyolysis | 2002 |
Malignant syndrome in Parkinson's disease: concept and review of the literature.
Topics: Antiparkinson Agents; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome | 2003 |
Movement disorders with neuroleptic drug treatment.
Topics: Acute Disease; Akathisia, Drug-Induced; Antipsychotic Agents; Basal Ganglia Diseases; Diagnosis, Differential; Dopamine; Dopamine Antagonists; Dyskinesia, Drug-Induced; Humans; Huntington Disease; Levodopa; Neuroleptic Malignant Syndrome; Parasympatholytics; Parkinson Disease, Secondary; Receptors, Dopamine; Time Factors; Tourette Syndrome | 1984 |
[Toxic and adverse neurological effects of anti-parkinsonian drugs].
Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Cholinergic Antagonists; Dopamine Agents; Dyskinesia, Drug-Induced; Humans; Levodopa; Neuroleptic Malignant Syndrome; Psychoses, Substance-Induced; Substance-Related Disorders | 1999 |
Clinical management of neuroleptic malignant syndrome.
Topics: Bromocriptine; Carbidopa; Dopamine Agonists; Drug Combinations; Electroconvulsive Therapy; Guidelines as Topic; Humans; Levodopa; Neuroleptic Malignant Syndrome; Physical Therapy Specialty | 2001 |
Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) and disseminated intravascular coagulation (DIC) in a patient with Parkinson's disease.
Topics: Aged; Antithrombins; Benzamidines; Dantrolene; Disseminated Intravascular Coagulation; Female; Guanidines; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease | 1992 |
Neuroleptic malignant syndrome. When levodopa withdrawal is the cause.
Topics: Aged; Carbidopa; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome | 1991 |
[Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) with disseminated intravascular coagulation (DIC) in a patient with Parkinson's disease].
Topics: Aged; Benzamidines; Dantrolene; Disseminated Intravascular Coagulation; Female; Guanidines; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease | 1991 |
[Neuroleptic malignant-like syndrome following levodopa withdrawal].
Topics: Aged; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome | 1990 |
60 other study(ies) available for levodopa and Neuroleptic Malignant Syndrome
Article | Year |
---|---|
Neuroleptic malignant-like syndrome associated multiple system atrophy: report on three cases.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Humans; Levodopa; Multiple System Atrophy; Neuroleptic Malignant Syndrome | 2022 |
Case report: cold medicines cause neuroleptic malignant-like syndrome in a patient with Parkinson's disease.
Topics: Antipsychotic Agents; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease | 2022 |
There is more to this fever than meets the eye: A case of neuroleptic malignant-like syndrome (NMLS) secondary to withdrawal of procyclidine and L-dopa on a background of long-standing flupenthixol depot use.
Topics: Antipsychotic Agents; Flupenthixol; Humans; Levodopa; Neuroleptic Malignant Syndrome; Procyclidine | 2023 |
Neuroleptic malignant-like syndrome causing thrombocytopaenia: a rare association.
Topics: Diagnosis, Differential; Glasgow Coma Scale; Humans; Levodopa; Male; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Patient Compliance; Thrombocytopenia | 2018 |
Postoperative hyperthermic syndrome following antiparkinsonian drugs withdrawal: the pitfall of enteral refeeding.
Topics: Aged, 80 and over; Antiparkinson Agents; Diagnosis, Differential; Drug Administration Schedule; Drug Interactions; Enteral Nutrition; Follow-Up Studies; Humans; Intubation, Gastrointestinal; Levodopa; Male; Malignant Hyperthermia; Neuroleptic Malignant Syndrome; Postoperative Period; Substance Withdrawal Syndrome | 2013 |
[Case of neuroleptic malignant syndrome following open heart surgery for thoracic aortic aneurysm with parkinson's disease].
Topics: Aged, 80 and over; Anesthesia; Aortic Aneurysm, Thoracic; Cardiac Surgical Procedures; Dantrolene; Extracorporeal Circulation; Female; Humans; Infusions, Intravenous; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease; Perioperative Care; Postoperative Complications | 2013 |
A neuroleptic malignant-like syndrome (NMLS) in a patient with Parkinson's disease resolved with rotigotine: a case report.
Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Dopamine Agonists; Female; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease; Tetrahydronaphthalenes; Thiophenes | 2014 |
Integrated theory to unify status among schizophrenia and manic depressive illness.
Topics: 5-Hydroxytryptophan; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Biopterins; Bipolar Disorder; Blood-Brain Barrier; Depression; Depression, Postpartum; Dopamine; Female; Hallucinations; Humans; Kynurenic Acid; Levodopa; Male; Neuroleptic Malignant Syndrome; Neurotransmitter Agents; Paranoid Disorders; Premenstrual Syndrome; Schizophrenia; Seasonal Affective Disorder; Serotonin; Serotonin Syndrome; Tyrosine | 2015 |
A 77-year-old man with Parkinson's disease and hyperthermia.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Combined Modality Therapy; Emergency Service, Hospital; Emergency Treatment; Follow-Up Studies; Humans; Levodopa; Male; Malignant Hyperthermia; Neuroleptic Malignant Syndrome; Parkinson Disease; Pramipexole; Risk Assessment; Treatment Outcome | 2008 |
Adjunct treatment with levodopa in a patient with dementia with Lewy bodies, delusions and severe neuroleptic hypersensitivity syndrome: some comments.
Topics: Antiparkinson Agents; Clozapine; Delusions; Drug Therapy, Combination; Humans; Levodopa; Lewy Body Disease; Movement Disorders; Neuroleptic Malignant Syndrome; Severity of Illness Index | 2010 |
Adjunct treatment with levodopa in a patient with dementia with Lewy bodies, delusions and severe neuroleptic hypersensitivity syndrome.
Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Clozapine; Delusions; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Levodopa; Lewy Body Disease; Neuroleptic Malignant Syndrome; Quetiapine Fumarate; Severity of Illness Index | 2010 |
[Dopaminergic malignant syndrome due to acute withdrawal of l-dopa].
Topics: Aged; Dopamine Agents; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome | 2010 |
An interaction between levodopa and enteral nutrition resulting in neuroleptic malignant-like syndrome and prolonged ICU stay.
Topics: Antiparkinson Agents; Carbidopa; Drug Therapy, Combination; Enteral Nutrition; Food-Drug Interactions; Humans; Intensive Care Units; Length of Stay; Levodopa; Male; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease | 2010 |
An uncommon adverse effect of levodopa withdrawal in a patient taking antipsychotic medication: neuroleptic malignant-like syndrome.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Dopamine Agonists; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome; Substance Withdrawal Syndrome | 2011 |
Neuroleptic malignant syndrome associated with the use of carbidopa/levodopa for dystonia in persons with cerebral palsy.
Topics: Carbidopa; Cerebral Palsy; Child; Dopamine Agents; Drug Therapy, Combination; Dystonia; Follow-Up Studies; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome | 2012 |
Neuroleptic malignant syndrome with prolonged catatonia in a dopa-responsive dystonia patient.
Topics: Adult; Catatonia; Dystonia; Electroencephalography; Female; GTP Cyclohydrolase; Humans; Levodopa; Neuroleptic Malignant Syndrome | 2002 |
Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up.
Topics: Confusion; Depression; Dopamine Agonists; Electric Stimulation Therapy; Follow-Up Studies; Levodopa; Mood Disorders; Neuroleptic Malignant Syndrome; Parkinson Disease; Quality of Life; Social Behavior Disorders; Substance Withdrawal Syndrome; Subthalamic Nucleus; Time; Treatment Outcome | 2003 |
Neuroleptic malignant syndrome-like, or--dopaminergic malignant syndrome--due to levodopa therapy withdrawal. Clinical features in 11 patients.
Topics: Adult; Aged; Analysis of Variance; Diagnosis, Differential; Female; Humans; Levodopa; Male; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome | 2003 |
Viral encephalitis complicated by neuroleptic malignant syndrome in a 7-year-old girl.
Topics: Anticonvulsants; Carbidopa; Child; Dopamine Agents; Drug Therapy, Combination; Encephalitis, Viral; Epilepsy, Tonic-Clonic; Female; Haloperidol; Humans; Hypnotics and Sedatives; Levodopa; Neuroleptic Malignant Syndrome; Psychomotor Agitation | 2003 |
Withdrawal of levodopa and other risk factors for malignant syndrome in Parkinson's disease.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Dehydration; Female; Fever; Health Status; Humans; Incidence; Levodopa; Male; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Risk Factors; Substance Withdrawal Syndrome | 2003 |
Serum creatine kinase is elevated in patients with Parkinson's disease: a case controlled study.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Case-Control Studies; Creatine Kinase; Female; Humans; Levodopa; Male; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome | 2003 |
Coagulation-fibrinolysis abnormalities in patients receiving antiparkinsonian agents.
Topics: Aged; alpha-2-Antiplasmin; Antifibrinolytic Agents; Antiparkinson Agents; Blood Coagulation Disorders; Case-Control Studies; Dopamine Agents; Drug Therapy, Combination; E-Selectin; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysin; Fibrinolysis; Humans; International Normalized Ratio; Levodopa; Male; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Peptide Fragments; Prothrombin; Thrombomodulin | 2003 |
[Malignant dopaminergic syndrome].
Topics: Aged; Dopamine Agents; Female; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease | 2004 |
Case of neuroleptic malignant-like syndrome precipitated by abrupt fava bean discontinuance.
Topics: Diagnosis, Differential; Humans; Levodopa; Male; Middle Aged; Neuroleptic Malignant Syndrome; Phytotherapy; Substance Withdrawal Syndrome; Vicia faba | 2005 |
Acute akinesia in Parkinson disease.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Akinetic Mutism; Apomorphine; Body Temperature; Cohort Studies; Comorbidity; Dopamine Agents; Dose-Response Relationship, Drug; Drug Resistance; Female; Gastrointestinal Diseases; Humans; Levodopa; Male; Middle Aged; Mortality; Neuroleptic Malignant Syndrome; Parkinson Disease; Prospective Studies; Recovery of Function; Treatment Failure | 2005 |
Electroconvulsive therapy in drug-induced psychiatric states and neuroleptic malignant syndrome.
Topics: Antiparkinson Agents; Dopamine Agents; Drug Administration Schedule; Electroconvulsive Therapy; Female; Humans; Levodopa; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Psychoses, Substance-Induced | 2005 |
Neuroleptic malignant syndrome in a patient with Parkinson's disease: a case study.
Topics: Aged; Antiparkinson Agents; Confusion; Dantrolene; Deep Brain Stimulation; Dehydration; Dopamine Agents; Drug Monitoring; Electrolytes; Fever; Humans; Leukocyte Count; Levodopa; Magnetic Resonance Imaging; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Nurse's Role; Nursing Assessment; Parkinson Disease; Physical Examination; Substance Withdrawal Syndrome; Time Factors; Urinalysis | 2005 |
Parkinsonism-hyperpyrexia syndrome: the role of electroconvulsive therapy.
Topics: Acetaminophen; Acyclovir; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Anxiety Agents; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antiparkinson Agents; Antiviral Agents; Anxiety; Carbidopa; Ceftriaxone; Cervical Vertebrae; Depression; Dexamethasone; Diazepam; Doxepin; Electroconvulsive Therapy; Humans; Levodopa; Male; Middle Aged; Neuroleptic Malignant Syndrome; Oxycodone; Pain; Parkinson Disease; Selegiline; Spinal Injuries | 2006 |
Neuroleptic malignant syndrome in a parkinsonian woman during the premenstrual period.
Topics: Body Temperature; Carbidopa; Drug Combinations; Female; Humans; Levodopa; Menstrual Cycle; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease | 1993 |
Management of neuroleptic malignant syndrome--a series of eight cases.
Topics: Adolescent; Adult; Bromocriptine; Carbidopa; Dantrolene; Dopamine Agents; Drug Combinations; Female; Humans; India; Levodopa; Male; Muscular Diseases; Neuroleptic Malignant Syndrome | 1993 |
Neuroleptic malignant syndrome--a cautionary tale and a surprising outcome.
Topics: Activities of Daily Living; Adaptation, Psychological; Adult; Antisocial Personality Disorder; Combined Modality Therapy; Critical Care; Dantrolene; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluphenazine; Follow-Up Studies; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome; Neurologic Examination; Schizoid Personality Disorder; Sick Role; Social Environment; Substance Withdrawal Syndrome | 1994 |
[A 75-year-old man with parkinsonism and delirium].
Topics: Aged; Delirium; Fever; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome; Parkinson Disease; Substantia Nigra | 1994 |
Amantadine withdrawal and neuroleptic malignant syndrome.
Topics: Amantadine; Bromocriptine; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome | 1993 |
Neuroleptic malignant syndrome postoperative onset due to levodopa withdrawal.
Topics: Anesthesia; Antiparkinson Agents; Female; Humans; Levodopa; Middle Aged; Neuroleptic Malignant Syndrome; Neuromuscular Blocking Agents; Postoperative Complications; Substance Withdrawal Syndrome | 1995 |
[Malignant-like neuroleptic syndrome: a sign to call attention to].
Topics: Aged; Antiparkinson Agents; Bromocriptine; Cephalosporins; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome; Parkinson Disease | 1995 |
Carbidopa/levodopa in the treatment of neuroleptic malignant syndrome.
Topics: Adult; Antiparkinson Agents; Carbidopa; Drug Therapy, Combination; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome | 1997 |
Intravenous injection of levodopa is more effective than dantrolene as therapy for neuroleptic malignant syndrome.
Topics: Adult; Dantrolene; Dopamine Agents; Female; Humans; Injections, Intravenous; Levodopa; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Schizophrenia | 1997 |
[Malignant syndrome associated with disseminated intravascular coagulation and a high level of amylase in serum, followed by diabetic coma in an elderly patient with Parkinson's disease during L-dopa therapy].
Topics: Aged; Amylases; Diabetic Coma; Disseminated Intravascular Coagulation; Female; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome | 1998 |
[A case of impending neuroleptic malignant syndrome associated with Shy-Drager syndrome].
Topics: Antiparkinson Agents; Carbidopa; Drug Therapy, Combination; Fludrocortisone; Humans; Levodopa; Male; Middle Aged; Neuroleptic Malignant Syndrome; Shy-Drager Syndrome | 1998 |
Neuroleptic malignant-like syndrome in an elderly patient caused by abrupt withdrawal of tolcapone, a-catechol-o-methyl transferase inhibitor.
Topics: Aged; Aged, 80 and over; Akathisia, Drug-Induced; Antiparkinson Agents; Benzophenones; Carbidopa; Catechol O-Methyltransferase Inhibitors; Confusion; Female; Humans; Levodopa; Neuroleptic Malignant Syndrome; Nitrophenols; Substance Withdrawal Syndrome; Tolcapone | 2000 |
Neuroleptic malignant syndrome without neuroleptics.
Topics: Antiparkinson Agents; Bromocriptine; Creatine Kinase; Diagnosis, Differential; Diagnostic Errors; Drug Therapy, Combination; Female; Humans; Levodopa; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome | 2001 |
Neuroleptic malignant syndrome in advanced Parkinson's disease.
Topics: Adult; Antiparkinson Agents; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome; Parkinson Disease; Secondary Prevention; Severity of Illness Index; Substance Withdrawal Syndrome | 2001 |
[Autopsied case of Parkinson disease with neuroleptic malignant-like syndrome and rhabdomyolysis].
Topics: Acute Kidney Injury; Aged; Brain; Humans; Kidney; Levodopa; Male; Muscles; Neuroleptic Malignant Syndrome; Parkinson Disease; Rhabdomyolysis | 1992 |
Apomorphine in malignant syndrome due to levodopa withdrawal.
Topics: Aged; Apomorphine; Female; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome | 1992 |
A 73-year-old woman with confusion, rigidity, and fever.
Topics: Aged; Carbidopa; Confusion; Drug Therapy, Combination; Female; Fever; Humans; Levodopa; Muscle Rigidity; Neuroleptic Malignant Syndrome; Parkinson Disease | 1991 |
[Case of malignant syndrome suggesting a central hyperthermic mechanism].
Topics: Antidepressive Agents; Female; Fever; Humans; Hypothalamus; Levodopa; Middle Aged; Morpholines; Neuroleptic Malignant Syndrome | 1991 |
Neuroleptic malignant syndrome complicating levodopa withdrawal.
Topics: Aged; Female; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome | 1991 |
Neuroleptic malignant syndrome without neuroleptics.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Depressive Disorder; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome; Tranylcypromine; Tryptophan | 1990 |
Clinical spectrum of neuroleptic malignant syndrome.
Topics: Adult; Drug Therapy, Combination; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome; Schizophrenia; Tranquilizing Agents | 1988 |
Neuroleptic malignant syndrome in striatonigral degeneration.
Topics: Aged; Corpus Striatum; Female; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome; Substantia Nigra | 1988 |
Successful treatment of levodopa-induced myoclonus and levodopa withdrawal-induced neuroleptic malignant syndrome. A case report.
Topics: Aged; Cyproheptadine; Humans; Levodopa; Male; Methysergide; Myoclonus; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome | 1988 |
Neuroleptic malignant syndrome responsive to carbidopa/levodopa: support for a dopaminergic pathogenesis.
Topics: Adult; Carbidopa; Drug Combinations; Haloperidol; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome; Psychotic Disorders | 1987 |
A case of neuroleptic malignant syndrome with myoglobinuric acute renal failure treated with dialysis and levodopa.
Topics: Acute Kidney Injury; Adult; Combined Modality Therapy; Female; Humans; Levodopa; Myoglobinuria; Neuroleptic Malignant Syndrome; Renal Dialysis; Rhabdomyolysis | 1987 |
Therapy of neuroleptic malignant syndrome.
Topics: Amantadine; Bromocriptine; Carbidopa; Combined Modality Therapy; Dantrolene; Diazepam; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electroconvulsive Therapy; Humans; Levodopa; Neuroleptic Malignant Syndrome; Receptors, Dopamine | 1986 |
Levodopa withdrawal and the neuroleptic malignant syndrome.
Topics: Humans; Levodopa; Neuroleptic Malignant Syndrome; Substance Withdrawal Syndrome | 1986 |
Levodopa withdrawal syndrome identical to neuroleptic malignant syndrome.
Topics: Female; Humans; Levodopa; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome | 1986 |
Hyperthermia after discontinuance of levodopa and bromocriptine therapy: impaired dopamine receptors a possible cause.
Topics: Body Temperature Regulation; Bromocriptine; Carbidopa; Drug Combinations; Female; Fever; Humans; Levodopa; Malignant Hyperthermia; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Receptors, Dopamine | 1985 |
A neuroleptic malignantlike syndrome due to levodopa therapy withdrawal.
Topics: Aged; Humans; Levodopa; Male; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome | 1985 |
Neuroleptic malignant syndrome: impaired dopaminergic systems?
Topics: Humans; Levodopa; Neuroleptic Malignant Syndrome | 1985 |
[Acute dopamine deficiency and malignant neuroleptic-like syndrome].
Topics: Antiparkinson Agents; Dopamine; Female; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Organic Chemicals; Parkinson Disease | 1992 |